Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 675 of 2873 entries
View as:

Proton Therapy With Capecitabine for Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00503932 Org: User:
Start: 07/31/07 End: 04/30/08 Due: 04/30/09

IADAPT-Third Phase

Phase: N/A Priority: Normal
NCT ID: NCT01698762 Org: User:
Start: 03/05/13 End: 04/21/21 Due: 04/21/22

Decitabine, Venetoclax, and Ponatinib for the Treatment of Philadelphia Chromosome-Positive Acute Myeloid Leukemia or Myeloid Blast Phase or Accelerated Phase Chronic Myelogenous Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT04188405 Org: User:
Start: 05/17/20 End: 09/01/25 Due: 09/01/26

Patient and Family Decision Making in the Palliative Care Setting

Phase: N/A Priority: Normal
NCT ID: NCT00682994 Org: User:
Start: 03/31/08 End: 08/31/12 Due: 08/31/13

Multimodal Imaging for Surveillance in Patients With Oral Potentially Malignant Disorders

Phase: N/A Priority: Normal
NCT ID: NCT02790853 Org: User:
Start: 05/25/16 End: 05/31/26 Due: 05/31/27

Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03594630 Org: User:
Start: 03/13/24 End: 10/31/26 Due: 10/31/27

Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their Caregivers

Phase: N/A Priority: Normal
NCT ID: NCT03948100 Org: User:
Start: 12/20/18 End: 04/30/27 Due: 04/30/28

Quality of Life and Function of Patients With Pelvic Tumors After Undergoing Hemipelvectomy

Phase: N/A Priority: Normal
NCT ID: NCT05134142 Org: User:
Start: 03/27/13 End: 04/30/27 Due: 04/30/28

Ibrutinib, Rituximab, Venetoclax, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03710772 Org: User:
Start: 05/01/19 End: 03/22/27 Due: 03/22/28

Pelvic Fractures and Radiation Therapy for Cervical Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00800644 Org: User:
Start: 11/05/08 End: 11/30/20 Due: 11/30/21

Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT02115295 Org: User:
Start: 05/19/14 End: 05/31/30 Due: 05/31/31

Doxil, Gemcitabine, and Velcade (PS341) in Advanced Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00500422 Org: User:
Start: 01/31/05 End: 11/30/12 Due: 11/30/13

Evaluating the Impact of Limited Compared With Intense Post-Operative Surveillance on Patient-Reported Outcomes in Patients With Stage II-III Soft Tissue Sarcoma of the Trunk and Extremities

Phase: N/A Priority: Normal
NCT ID: NCT04751409 Org: User:
Start: 12/28/20 End: 12/31/27 Due: 12/31/28

Oxidative Phosphorylation Inhibitor IACS-010759 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT02882321 Org: User:
Start: 09/29/16 End: 04/15/22 Due: 04/15/23

Bortezomib and Chemotherapy in Treating Participants With Lymphoid Malignancies Undergoing Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT00439556 Org: User:
Start: 02/13/07 End: 06/07/18 Due: 06/07/19

Everolimus and Anakinra or Denosumab in Treating Participants With Relapsed or Refractory Advanced Cancers

Phase: N/A Priority: Normal
NCT ID: NCT01624766 Org: User:
Start: 06/19/12 End: 02/24/21 Due: 02/24/22

Patient Satisfaction & Quality Of Life in Patients With Cervical Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00473798 Org: User:
Start: 07/01/99 End: 06/05/20 Due: 06/05/21

An Investigational Device (Millar Mikro-Tip Catheter) and Imaging Scan (Shear Wave Elastography) in Measuring Tumor Pressure and Stiffness in Patients With Solid Tumors Undergoing Ultrasound-Guided Biopsy

Phase: N/A Priority: Normal
NCT ID: NCT04054154 Org: User:
Start: 12/29/15 End: 12/31/26 Due: 12/31/27

Neuropathic Pain in Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01846286 Org: User:
Start: 10/15/12 End: 12/31/22 Due: 12/31/23

Neoadjuvant and Adjuvant Checkpoint Blockade

Phase: N/A Priority: Normal
NCT ID: NCT02519322 Org: User:
Start: 02/02/16 End: 01/26/23 Due: 01/26/24

Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemically Recurrent Prostate Cancer, RESTART Study

Phase: N/A Priority: Normal
NCT ID: NCT04585932 Org: User:
Start: 11/24/20 End: 01/08/21 Due: 01/08/22

Symptom Burden in Chronic Myeloid Leukemia (CML)

Phase: N/A Priority: Normal
NCT ID: NCT01046305 Org: User:
Start: 11/30/09 End: 11/30/20 Due: 11/30/21

Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00436657 Org: User:
Start: 02/28/07 End: 04/30/11 Due: 04/30/12

Ancillary Study GOG 158: Survival Analysis Based on Reclassification to a Two-Tier Grading System

Phase: N/A Priority: Normal
NCT ID: NCT00837993 Org: User:
Start: 08/31/07 End: 12/31/12 Due: 12/31/13

Celecoxib as Adjuvant Biologic Therapy in Patients With Head and Neck and Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00527982 Org: User:
Start: 09/30/05 End: 09/30/08 Due: 09/30/09